Maria Fardis
2020
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Option Awards | $8,139,400 |
| Salary | $600,000 |
| Total | $9,039,400 |
Fardis received $8.1M in option awards, accounting for 90% of the total pay in 2020.
Fardis also received $300K in non-equity incentive plan and $600K in salary.
Rankings
In 2020, Maria Fardis' compensation ranked 980th out of 13,090 executives tracked by ExecPay. In other words, Fardis earned more than 92.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 980 out of 13,090 | 93rd |
Division Manufacturing | 342 out of 5,617 | 94th |
Major group Chemicals And Allied Products | 117 out of 2,248 | 95th |
Industry group Drugs | 103 out of 1,948 | 95th |
Industry Biological Products, Except Diagnostic Substances | 27 out of 411 | 93rd |
Pay ratio
| Maria Fardis' Pay | $9,039,400 |
|---|---|
| Median Employee's Pay | $445,643 |
| Pay Ratio | 20to 1 |
In 2020, the annual total compensation of Maria Fardis was $9,039,400.
The annual total compensation of the median employee at Lion Biotechnologies was $445,643.
The ratio of Maria Fardis' pay to the pay of median employee was therefore 20 to one.
Fardis' colleagues
We found five more compensation records of executives who worked with Maria Fardis at Lion Biotechnologies in 2020.
2020
Jean-Marc Bellemin
Lion Biotechnologies
Chief Financial Officer
2020
Frederick Vogt
Lion Biotechnologies
General Counsel
2020
Friedrich Finckenstein
Lion Biotechnologies
Chief Medical Officer
2020
Michael Swartzburg
Lion Biotechnologies
Former Vice President, Finance and interim Principal Financial Officer and Principal Accounting Officer
2020
Timothy Morris
Lion Biotechnologies